Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

2025, Fourth Quarter and Financial Position

Digest more
Top News
Overview
Highlights
 · 2d
Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its fourth quarter and full ...

Continue reading

 · 1d
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
TMCnet · 1d
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
 · 1d
Texas Roadhouse, Inc. Announces Fourth Quarter 2025 Results
Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the fourth quarter and fiscal year ended December 30, 2025.

Continue reading

 · 1d
Kinross reports 2025 fourth-quarter and full-year results
TMCnet · 1d
Socket Mobile Reports Fourth Quarter 2025 and Full Year Results
 · 1d
Akamai Reports Fourth Quarter 2025 and Full-Year 2025 Financial Results
“Akamai delivered strong year-end performance, with better-than-expected results on the top and bottom lines. We were particularly pleased to achieve 36% year-over-year revenue growth in Q4 across our...

Continue reading

 · 1d
Inseego Reports Fourth Quarter and Full-Year 2025 Financial Results
 · 1d
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results
Seeking Alpha
6mon

Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update

SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its second quarter ended June 30, 2025.
Nasdaq
9mon

Recursion to Report First Quarter 2025 Financial Results on May 5, 2025

Recursion is scheduled to report its first quarter 2025 financial results, providing transparency and updates to investors, which can enhance trust and investor relations. The company'searnings callwill be accessible via multiple platforms (X, LinkedIn ...
  • Privacy
  • Terms